Search results

Page results

• Long-term follow-up

  This information aims to help answer your questions about long-term follow-up care.

• Research to improve hospital treatment for people who use opioids

  UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.

• David Beckham brings joy to young cancer patients

  Young cancer patients and staff couldn’t believe their eyes when David Beckham paid a visit to the University College Hospital Macmillan Cancer Centre earlier this year.

• Getting Ready for Transition (GReaT) to secondary school

  Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023. 

• National roll-out of Child Houses to support victims of sexual abuse announced at UCLH’s Lighthouse

  Wes Streeting, health and social care secretary, and Jess Phillips, minister for safeguarding, joined Sadiq Khan, mayor of London, and Kaya Comer-Schwartz, deputy mayor for policing and crime, at UCLH’s Lighthouse to announce a national roll-out of Child Houses to all NHS regions.

• Alternating vaccines trial to include two additional vaccines

  The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.

• Research to make sure young people with lymphoma get the right amount of chemotherapy

  A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).

• Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease

  A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.

• UCLH to lead data initiative to improve care for myeloma patients

  UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).

• Blood cancer patients to get new cutting-edge treatment on the NHS

  Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.